Lead the charge in advancing degrader molecule discovery for CNS indications. Develop and optimize assays to assess compound engagement, ensuring robust data integration and collaboration across teams for groundbreaking neurodegenerative research.

Lead the charge in advancing CMC strategies, overseeing drug development from preclinical to launch. Drive cross-functional collaboration to ensure robust supply and regulatory compliance while guiding a high-performing Technical Operations team.

Lead the charge in clinical development for neurodegenerative therapies, collaborating with cross-functional teams to design, execute, and oversee pivotal trials while ensuring regulatory compliance to improve patient outcomes.